Countries fail to reach a compromise in TPP talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Countries fail to reach a compromise in TPP talks

After four days of negotiations, international delegates from 12 countries have failed to reach a compromise over the Trans Pacific Partnership (TPP) Agreement.

The Office of the United States Trade Representative issued a statement yesterday claiming that "substantial progress" has been made in the TPP talks, which are now expected to continue into next year.

The news follows Monday's release by whistleblowing site WikiLeaks of two documents that suggest the US is isolated in its positions on many issues including intellectual property, and is exerting "great pressure" on other countries to comply with its demands.

One of the documents, an internal memo, records "large differences that continue in most areas of the chapter" on intellectual property. It recounts the meeting chair recording solutions "coming from the US position", prompting other countries to demand corrections to the text, which could later be used by the US as a basis for reaching an agreement.

The memo also describes the US proposals on Investor State Dispute Settlement, which allow companies to directly sue governments at a secret international arbitration tribunal, as one of "one of the most significant barriers to closing the chapter" on investment.

The other document, a spreadsheet outlining the positions of the countries on the various issues, shows the US as the sole supporter of proposals such as linkage requirements for pharmaceuticals, the criminalisation of copyright infringement and rules against parallel importation, which was judged to be legal by its own Supreme Court in Kirtsaeng v John Wiley.

The countries involved in the TPP negotiations are Australia, New Zealand, the US, Peru, Chile, Mexico, Canada, Singapore, Brunei, Malaysia, Japan and Vietnam.

Yesterday, six members of US Congress wrote to President Barack Obama arguing that the "secret" negotiations benefit pharmaceutical companies at the expense of public health. The writers, all Democrats, urged the president not to make any final trade agreements "that affect critical health issues" until politicians and members of the public have had the opportunity to review and comment on the proposals.

Joseph Stiglitz, a Nobel prize-winning economist from the Columbia University School of Business, has also written to the negotiators, arguing that several of the proposals would weaken the 2001 Doha Declaration on TRIPS and Public Health.

Separately, 27 organisations and over 70 individuals have signed on to a letter by Knowledge Ecology International protesting the proposal to extend copyright protection to life plus 70 years. The letter argues the extension will result in the loss of countless owned but uncommercialised works and will be "costly to consumers and performers, while benefiting persons and corporate owners that had nothing to do with the creation of the work."

more from across site and SHARED ros bottom lb

More from across our site

Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Yonatan Drori, attorney at Drori-Stav IP in Israel, explains why foreign counsel must treat Israel’s patent disclosure requirements as an ongoing obligation, rather than a one-off formality
Gift this article